89Zr-DFO-MSTP2109A

· Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 89Zr-DFO-MSTP2109A, covering 2024-10-02 to 2024-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer [Phase 1, Phase 2]